Lilly pushes deeper into men’s health

In an effort to become a leader in men's health, Cialis maker Eli Lilly (NYSE: LLY) is reporting progress in the battle to help men fight erectile dysfunction. For example, this week the drugmaker had advanced an experimental drug for treating enlarged prostate from early-stage to middle-stage clinical trials. The company is enrolling men with enlarged prostates in a 24-week test to see how well the drug, known as LY500307, can treat the ailment. And earlier this year, the...